Library
Stigma as a barrier to cancer palliative care outcomes among people with HIV in India
Cancer incidence is rising among people living with HIV, as improved access to antiretroviral treatment has led to an increased life expectancy worldwide, including in India, thereby also increasing the need for palliative care services. While it is well known that HIV stigma acts as a barrier to engagement and retention in HIV care, we do not yet know how the additional stigma of cancer may compound this problem. The proposed study would meet this need by adapting our current India HIV stigma measures and African palliative outcome measures for use among people living with co-morbid HIV and cancer in India, and to adapt a novel evidence-based African intervention to improve access to effective palliation and end-of-life decisions throughout the care continuum in India. This is a two year study conducted in collaboration with our colleagues at Kasturba Medical College, Manipal.
PIs: Maria L. Ekstrand PhD, Naveen Salins MD
Consultant: Richard Harding PhD
UCSF-based Project Staff: Elsa Heylen MA, Amanda Mazur MS
Sep 13, 2018 - Aug 31, 2020
National Gay Men's HIV/AIDS Awareness Day – September 27, 2018 [booklet]
This brochure lists research focusing on HIV testing and helpful resources produced by CAPS/PRC. You might use it to:
- Stay up-to-date on research and learn what we found out from research
- Use the materials in trainings/presentations
- Advocate for services/funding
- Write grants
- Develop new or modify existing HIV prevention programs
- Evaluate current programs
- Connect with CAPS/PRC to develop new projects.
Lead researchers (PIs) are listed for each study. This brochure was prepared by the Community Engagement (CE) Core, previously known as the Technology and Information Exchange (TIE) Core: “Tying research and community together.”
Influence of Stigma and Discrimination on HIV Risk among Men in China
- In Phase 1, we will explore the range of management strategies used to cope with MSM stigma via 30 in-depth qualitative interviews with MSM.
- In Phase 2, we will develop, using Phase 1 qualitative data and adapting existing quantitative scales, culturally-relevant measures of explanatory constructs of interest (e.g., MSM stigma management) to establish reliability and validity (N=170).
- In Phase 3, we will examine potential mediators (e.g., stigma management strategies, psychological distress, sexual contexts/situations) that explain how MSM stigma are linked to sexual risk for HIV with a respondent-driven sample of 500 MSM who will complete baseline and two follow-up assessments at 6 and 12 months.